About Skysis
Skysis is a Healthcare company based in Scottsdale (United States) founded in 2011 by Jeff Martini, Norman Stalsberg, and Dan Twibell, and was acquired by Fishawack in April 2020. It operates as a biopharma consulting services are provided by Skysis to industry clients. Skysis offers products and services including Marketing Consulting, Medical Policy Consulting, Evidence Consulting, and Data and Technology Consulting. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its competitors include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Skysis was established in 2011 in Scottsdale, United States, as a provider of consulting services within the biopharma sector. Advisory support is offered to biopharmaceutical firms on operational and strategic matters. The company is directed by co-founders Jeff Martini and Dan Twibell, with Norman Stalsberg as founder. Focus is placed on tailored solutions for drug development and regulatory challenges in the North American market.
- Headquarters Scottsdale, United States
- Founders Jeff Martini, Norman Stalsberg, Dan Twibell
- SectorsHealthcare
- Website skysis.com
- Social LinkedIn
- Acquired by Fishawack (Apr 2020)
Products & Services of Skysis
Skysis offers a comprehensive portfolio of products and services, including Marketing Consulting, Medical Policy Consulting, Evidence Consulting, and Data and Technology Consulting.
Provides strategies for healthcare marketing and promotion.
Offers advice on medical policy and access development.
Delivers value and evidence-based healthcare consulting.
Focuses on data management and media technology solutions.
Investors in Skysis
Skysis has secured backing from 1 investor. Prominent investors backing the company include Fishawack.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fully integrated cross-border services are delivered to global pharmaceutical organizations. | 2001 | fishawack.com | Brighton, United Kingdom |
Investor details for Skysis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Skysis
3 people are tracked at Skysis (3 in leadership).
| Name | Role | Group |
|---|---|---|
Jeff Martini | Co-Founder & Managing Director | Leadership |
Norman Stalsberg | Founder | Leadership |
Dan Twibell | Co-Founder & Managing Director | Leadership |
Complete people profiles for Skysis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Skysis
2 dated milestones of Skysis across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Skysis is founded.
- Exit Acquired by Fishawack.
Competitors of Skysis
Skysis has 9 listed competitors in our database, 4 of them funded. They include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $255.15M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| fishawack.com | 2001 | Brighton, United Kingdom | $23.59M | 45 | Fully integrated cross-border services are delivered to global pharmaceutical organizations. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| diaceutics.com | 2005 | Belfast, United Kingdom | – | 133 | Precision medicine integration is facilitated through analytics and services. | |
| sancilio.com | 2005 | Riviera Beach, United States | $27.25M | – | Innovative drug candidates are developed using proprietary Advanced Lipid Technologies. |
Detailed competitors of Skysis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Skysis (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Skysis
Complete news archive for Skysis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Skysis
Skysis was founded in 2011.
Skysis is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.
Skysis was established in 2011 in Scottsdale, United States, as a provider of consulting services within the biopharma sector. Advisory support is offered to biopharmaceutical firms on operational and strategic matters. The company is directed by co-founders Jeff Martini and Dan Twibell, with Norman Stalsberg as founder. Focus is placed on tailored solutions for drug development and regulatory challenges in the North American market.
Skysis's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Skysis offers Marketing Consulting, Medical Policy Consulting, Evidence Consulting, and Data and Technology Consulting.
Skysis has 1 investor. Key investors include Fishawack.
Yes. Skysis was acquired by Fishawack in April 2020.